Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 841 AL 855

Are we ready to use anti-amyloid therapy in Alzheimer's disease?

Brucki SMD, César-Freitas KG, Spera RR, Borges CR, Smid J.

Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):15-23. doi: 10.1590/0004-282X-ANP-2022-S117.

Non-coding RNAs in Alzheimer's disease: perspectives from omics studies

Wang E, Lemos Duarte M, Rothman LE, Cai D, Zhang B.

Hum Mol Genet. 2022 Oct 20;31(R1):R54-R61. doi: 10.1093/hmg/ddac202.

Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide

Lutz MW, Khachaturian AS, Zetterberg H, Blennow K, Willette AA, Mielke MM, Hayden KM, Dodge HH, Tang Y, Greenberg BD, Kukull WA, Khachaturian ZS.

Alzheimers Dement. 2022 Sep;18(9):1595-1601. doi: 10.1002/alz.12772. Epub 2022 Aug 25.

Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-analysis

Rostamzadeh A, Bohr L, Wagner M, Baethge C, Jessen F.

Neurology. 2022 Oct 25;99(17):e1866-e1874. doi: 10.1212/WNL.0000000000201072. Epub 2022 Aug 26.

Exploring Plausible Therapeutic Targets for Alzheimer's Disease using Multi-omics Approach, Machine Learning and Docking

Parvathy Dharshini SA, Sneha NP, Yesudhas D, Kulandaisamy A, Rangaswamy U, Shanmugam A, Taguchi YH, Gromiha MM.

Curr Top Med Chem. 2022;22(22):1868-1879. doi: 10.2174/1568026622666220902110115.

Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease

Gao C, Shen X, Tan Y, Chen S.

J Neuroinflammation. 2022 Sep 4;19(1):215. doi: 10.1186/s12974-022-02580-1.

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, Mishra A, Ali M, Andrade V, Bellenguez C, Kleineidam L, Küçükali F, Sung YJ, Tesí N, Vromen EM, Wightman DP, Alcolea D, Alegret M, Alvarez I, Amouyel P, Athanasiu L, Bahrami S, Bailly H, Belbin O, Bergh S, Bertram L, Biessels GJ, Blennow K, Blesa R, Boada M, Boland A, Buerger K, Carracedo Á, Cervera-Carles L, Chene G, Claassen JAHR, Debette S, Deleuze JF, de Deyn PP, Diehl-Schmid J, Djurovic S, Dols-Icardo O, Dufouil C, Duron E, Düzel E; EADB consortium; Fladby T, Fortea J, Frölich L, García-González P, Garcia-Martinez M, Giegling I, Goldhardt O, Gobom J, Grimmer T, Haapasalo A, Hampel H, Hanon O, Hausner L, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernández I, Herukka SK, Holstege H, Jarholm J, Kern S, Knapskog AB, Koivisto AM, Kornhuber J, Kuulasmaa T, Lage C, Laske C, Leinonen V, Lewczuk P, Lleó A, de Munain AL, Lopez-Garcia S, Maier W, Marquié M, Mol MO, Montrreal L, Moreno F, Moreno-Grau S, Nicolas G, Nöthen MM, Orellana A, Pålhaugen L, Papma JM, Pasquier F, Perneczky R, Peters O, Pijnenburg YAL, Popp J, Posthuma D, Pozueta A, Priller J, Puerta R, Quintela I, et al.

Acta Neuropathol. 2022 Nov;144(5):821-842. doi: 10.1007/s00401-022-02454-z. Epub 2022 Sep 6.

Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review

Sagües-Sesé E, Rioja J, Garzón-Maldonado FJ, Narváez M, García-Arnés JA, García-Casares N.

J Alzheimers Dis. 2022;90(1):1-13. doi: 10.3233/JAD-220688.

Clinical utility of cerebrospinal fluid biomarkers in the evaluation of cognitive impairment: a systematic review and meta-analysis

Hazan J, Wing M, Liu KY, Reeves S, Howard R.

J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):113-120. doi: 10.1136/jnnp-2022-329530. Epub 2022 Sep 12.

In vivo tau staging in Alzheimer's disease

Therriault J, Gauthier S, Rosa-Neto P.

Aging (Albany NY). 2022 Sep 14;14(17):6842-6843. doi: 10.18632/aging.204293. Epub 2022 Sep 14.

A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives

Li L, Yu X, Sheng C, Jiang X, Zhang Q, Han Y, Jiang J.

Transl Neurodegener. 2022 Sep 15;11(1):42. doi: 10.1186/s40035-022-00315-z.

Alzheimer's Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers

Baldeiras I, Silva-Spínola A, Lima M, Leitão MJ, Durães J, Vieira D, Tábuas-Pereira M, Cruz VT, Rocha R, Alves L, Machado Á, Milheiro M, Santiago B, Santana I.

J Alzheimers Dis. 2022;90(1):419-432. doi: 10.3233/JAD-220587.

Raman Spectroscopy Techniques for the Investigation and Diagnosis of Alzheimer's Disease

Polykretis P, Banchelli M, D'Andrea C, de Angelis M, Matteini P.

Front Biosci (Schol Ed). 2022 Aug 1;14(3):22. doi: 10.31083/j.fbs1403022.

Demand Coupling Drives Neurodegeneration: A Model of Age-Related Cognitive Decline and Dementia

Turknett J, Wood TR.

Cells. 2022 Sep 7;11(18):2789. doi: 10.3390/cells11182789.

The Feasibility of Early Alzheimer's Disease Diagnosis Using a Neural Network Hybrid Platform

Yu X, Srivastava S, Huang S, Hayden EY, Teplow DB, Xie YH.

Biosensors (Basel). 2022 Sep 13;12(9):753. doi: 10.3390/bios12090753.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias